RSV Ped-011
Research payments
$156,055
Through program year 2020, $156,055 in research payments was reported against RSV Ped-011, across 12 payments, paid by GlaxoSmithKline, LLC..
- Paid by
- GlaxoSmithKline, LLC.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $30,469 | 4 |
| 2019 | Research | $125,587 | 8 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- James Campbell Baltimore, MD Named on 2 payments
- William Koch Richmond, VA Named on 2 payments
- Richard Aguilar Nampa, ID Named on 2 payments
- Wendy Daly Louisville, KY Named on 1 payment
- Khozema Palanpurwala Conroe, TX Named on 1 payment
- Marquita Anderson Bedford, TX Named on 1 payment
- Jeffrey Wampler Louisville, KY Named on 1 payment
- Evan Anderson Atlanta, GA Named on 1 payment
- Shelly Senders Mayfield Heights, OH Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.